» Articles » PMID: 30088951

FOXO1 and ETV6 Genes May Represent Novel Regulators of Splicing Factor Expression in Cellular Senescence

Overview
Journal FASEB J
Specialties Biology
Physiology
Date 2018 Aug 9
PMID 30088951
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Cellular plasticity is a key facet of cellular homeostasis requiring correct temporal and spatial patterns of alternative splicing. Splicing factors, which orchestrate this process, demonstrate age-related dysregulation of expression; they are emerging as potential influences on aging and longevity. The upstream drivers of these alterations are still unclear but may involve aberrant cellular signaling. We compared the phosphorylation status of proteins in multiple signaling pathways in early and late passage human primary fibroblasts. We then assessed the impact of chemical inhibition or targeted knockdown of direct downstream targets of the ERK and AKT pathways on splicing factor expression, cellular senescence, and proliferation kinetics in senescent primary human fibroblasts. Components of the ERK and AKT signaling pathways demonstrated altered activation during cellular aging. Inhibition of AKT and ERK pathways led to up-regulation of splicing factor expression, reduction in senescent cell load, and partial reversal of multiple cellular senescence phenotypes in a dose-dependent manner. Furthermore, targeted knockdown of the genes encoding the downstream targets FOXO1 or ETV6 was sufficient to mimic these observations. Our results suggest that age-associated dysregulation of splicing factor expression and cellular senescence may derive in part from altered activity of ERK and AKT signaling and may act in part through the ETV6 and FOXO1 transcription factors. Targeting the activity of downstream effectors of ERK and AKT may therefore represent promising targets for future therapeutic intervention.-Latorre, E., Ostler, E. L., Faragher, R. G. A., Harries, L. W. FOXO1 and ETV6 genes may represent novel regulators of splicing factor expression in cellular senescence.

Citing Articles

Lamin B1 regulates RNA splicing factor expression by modulating the spatial positioning and chromatin interactions of the gene locus.

Shin G, Jo A, Kim J, Kim J, Kim C, An M Anim Cells Syst (Seoul). 2025; 29(1):149-162.

PMID: 39968360 PMC: 11834782. DOI: 10.1080/19768354.2025.2465325.


Alternative Splicing: Emerging Roles in Anti-Aging Strategies.

Gao L, Jia R Biomolecules. 2025; 15(1).

PMID: 39858525 PMC: 11763286. DOI: 10.3390/biom15010131.


A nutrigeroscience approach: Dietary macronutrients and cellular senescence.

Calubag M, Robbins P, Lamming D Cell Metab. 2024; 36(9):1914-1944.

PMID: 39178854 PMC: 11386599. DOI: 10.1016/j.cmet.2024.07.025.


A defective splicing machinery promotes senescence through MDM4 alternative splicing.

Deschenes M, Durand M, Olivier M, Pellerin-Viger A, Rodier F, Chabot B Aging Cell. 2024; 23(11):e14301.

PMID: 39118304 PMC: 11561654. DOI: 10.1111/acel.14301.


Repurposing Drugs for Senotherapeutic Effect: Potential Senomorphic Effects of Female Synthetic Hormones.

Bramwell L, Frankum R, Harries L Cells. 2024; 13(6.

PMID: 38534362 PMC: 10969307. DOI: 10.3390/cells13060517.